Anticoagulation therapy and the 2008 Joint Commission National Patient Safety Goals
“Anticoagulation is a high risk treatment, which commonly leads to adverse drug events due to the complexity of dosing these medications, monitoring their effects and ensuring patient compliance with outpatient therapy.” -- The Joint Commission
On January 23, 2008, Premier conducted an educational webcast to discuss The Joint Commission’s 2008 National Patient Safety Goals for anticoagulation therapy. Speakers will reviewed The Joint Commission markers that have been set for the planning, developing and tracking of milestones through calendar year 2008; and overviewed the implementation of the required January 1, 2009 anticoagulation protocols.
Presentations from member healthcare facilities with established anticoagulation programs followed the Joint Commission overview. Speakers highlighted the anticoagulation issues previously faced in their hospitals and how, through the development of new programs, they have been able to improve the quality of patient care by decreasing the risk of adverse events. An interactive Q&A session concluded the webcast.
Archives
Listen to the MP3 audio file from the session and Download the slide presentation from the webcast.
Premier resources
- Joint Commission Medication Issues listserv - Patient Safety preparedness is an important membership focus. Membership discussion on the Joint Commission is available through the mail list service (member login required).
- Anticoagulation flow sheet documents may be accessed through the Premier Pharmacy Affairs Web site (member login required).
- Premier Consulting Solutions - Supported by more than 100 subject matter experts and vast data repositories, PCS provides healthcare facilities and systems guidance and improvements in organizational transformation, supply chain transformation, service line solutions, patient throughput, clinical and regulatory areas, facilities and capital and revenue cycle.
- Premier Performance Improvement Portal - This improvement and efficiency toolkit used by black belt experts, health system managers and leading hospitals allows you to access other consultants' tools and expertise 24/7. Receive best practices, templates and how-tos from experts around the country.
- The Centers for Medicare and Medicaid Services (CMS) has chosen eight hospital-associated conditions (HACs) for which it will not provide additional reimbursement should they occur, effective October 2008. Premier's Safety Institute offers detailed information on these CMS conditions. Additionally, CMS is reviewing other potentially preventable HACs to add to this list of conditions for 2009, including pulmonary embolism (PE) and venous thromboembolism (VTE).
- Premier's Safety Institute contains a guideline on venous thromboembolism (VTE) on its site, located under the heading, "Prevention of Venous Thromboembolism 2004-2007."
Joint Commission resources
2008 National Patient Safety Goals - Goal 3E is to "Reduce the likelihood of patient harm associated with the use of anticoagulation therapy"
For more assistance, please contact Premier's Solution Center at 877.777.1552 or solutioncenter@premierinc.com.